1. Home
  2. WTBA vs AGEN Comparison

WTBA vs AGEN Comparison

Compare WTBA & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Bancorporation

WTBA

West Bancorporation

HOLD

Current Price

$23.97

Market Cap

387.6M

Sector

Finance

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.50

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTBA
AGEN
Founded
1893
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
387.6M
147.4M
IPO Year
2002
1999

Fundamental Metrics

Financial Performance
Metric
WTBA
AGEN
Price
$23.97
$3.50
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$24.00
$14.50
AVG Volume (30 Days)
26.1K
744.4K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
4.17%
N/A
EPS Growth
35.21
100.00
EPS
0.61
1.02
Revenue
N/A
$42,877,086.00
Revenue This Year
$23.80
$107.63
Revenue Next Year
$9.39
N/A
P/E Ratio
$39.20
$3.32
Revenue Growth
N/A
89.95
52 Week Low
$17.50
$2.71
52 Week High
$26.60
$7.34

Technical Indicators

Market Signals
Indicator
WTBA
AGEN
Relative Strength Index (RSI) 52.76 48.00
Support Level $23.49 $2.93
Resistance Level $24.25 $4.72
Average True Range (ATR) 0.50 0.24
MACD 0.09 0.01
Stochastic Oscillator 90.85 68.46

Price Performance

Historical Comparison
WTBA
AGEN

About WTBA West Bancorporation

West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: